Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04062500

Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure

The purpose of this registry is to compile a large clinical database on the medical management of patients hospitalized with acute heart failure, using information collected from hospitals across China.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Heart Failure Cardiovascular Diseases Heart Diseases

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Registry for Longitudinal mortality and therapy in patients with Heart Failure is a large, multicenter, prospective, open-label registry of the management of patients treated in the hospital for acute heart failure in China. The objective of this study is to investigate the clinical features and prognosis of patients with heart failure, and discover the characteristics of high-risk heart failure patients, and elucidate critical factors which predict the development and outcomes of symptomatic heart failure patients.

  • To elucidate the clinical characteristics and prognostic risks of patients with heart failure.
  • To study the characteristics of high-risk heart failure patients and predict the key factors for the development of symptomatic heart failure patients.
  • To elucidate the compliance of patients with heart failure and the incidence of adverse drug effects.
  • To investigate the effect of self-management on outcomes in patients with heart failure.
  • To elucidate critical factors associated with the development and outcomes of heart failure.
  • To investigate hospitalization expenses for heart failure.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1. 18 years and older. 2. Meet the diagnostic criteria of China 2018 or JACC/AHA 2017 or ESC 2016 heart failure guidelines.
  • Agree to be tested and sign an informed consent certificate.

Exclusion criteria

  • 1. Age<18 years old. 2. Patients who refused to participate. 3. Patients may have a life expectancy of less than 1 years due to non- heart failure clinical conditions.

Treatment and study plan

Mortality and Rehospitalization rate

Other

Mortality and Re-hospitalization of acute decompensated heart failure

Primary outcomes

  1. Mortality of acute decompensated heart failure

    Time frame: 10 years

    In-hospital and Annual mortality

  2. Re-hospitalization rate

    Time frame: 10 years

    Re-hospitalization of acute decompensated heart failure

Study contacts

Contact information is provided by the study sponsor or research team.

Dachun Xu, PhD

CONTACT

[email protected]

18917684045 ext. +86

Sponsors and collaborators

Lead sponsor

Shanghai 10th People's Hospital

Other

Collaborators

  • Beijing Chao Yang Hospital
  • First Affiliated Hospital, Sun Yat-Sen University
  • First Hospital of China Medical University
  • Nanfang Hospital, Southern Medical University
  • Ningbo Medical Center Lihuili Hospital
  • People's Hospital of Xinjiang Uygur Autonomous Region
  • Shaanxi University of Chinese Medicine
  • The First Affiliated Hospital of Zhengzhou University
  • Xuhui Central Hospital, Shanghai
  • Yangpu District Central Hospital Affiliated to Tongji University

Registry information

Official study title

Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure (GREARTWAL Study)

Acronym: GREARTWAL

Important dates

Study start
2018
Primary completion
2020
Study completion
2027
First posted
Aug 20, 2019
Registry last updated
Aug 17, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.